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Cerebellar Long-Term Synaptic Depression Requires
PKC-Mediated Activation of CPI-17,
a Myosin/Moesin Phosphatase Inhibitor
of which is also required (Linden and Connor, 1991;
Hartell, 1994; De Zeeuw et al., 1998; Freeman et al.,
1998). While PKC activation is necessary, continued
PKC activity is not required for LTD: application of PKC
inhibitors 15 min after the induction of LTD does not
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alter its time course (Linden and Connor, 1991). In addi-2 Department of Neuroscience
tion, some laboratories have reported that a cascadeJohns Hopkins University School of Medicine
involving NO, cGMP, and cGMP-dependent protein ki-725 N. Wolfe Street
nase is involved in the induction of cerebellar LTD (seeBaltimore, Maryland 21205
Bear and Linden, 2000; Ito, 2001, for review).
Cerebellar LTD may be detected using exogenous test
pulses of AMPA receptor agonists such as glutamate,Summary
quisqualate, or AMPA in various preparations including
intact cerebellum (Ito et al., 1982), slices (Crepel andCerebellar LTD requires brief activation of PKC and is
Krupa, 1988), and cell cultures (Linden et al., 1991). Fur-expressed as a functional downregulation of AMPA
thermore, cerebellar LTD can even be seen in prepara-receptors. Modulation of vascular smooth-muscle con-
tions that lack viable presynaptic terminals (Linden,traction by G protein-coupled receptors (called Ca2
1994; Narasimhan and Linden, 1996). Thus, it appearssensitization) also involves PKC phosphorylation and
as if cerebellar LTD involves some form of functionalactivation of a specific inhibitor of myosin/moesin
downregulation of postsynaptic AMPA receptors. Thephosphatase (MMP). This inhibitor, called CPI-17, is also
expression of cerebellar LTD is not associated withexpressed in brain. Here, we tested the hypothesis
changes in the kinetics, desensitization, agonist affinity,that LTD, like Ca2 sensitization, employs a PKC/CPI-
or unitary conductance of AMPA receptors (Linden,17 cascade. Introduction of activated recombinant
2001). However, LTD expression is likely to involve aCPI-17 into cells produced a use-dependent atten-
reduction of the number of AMPA receptors in the post-uation of glutamate-evoked responses and occluded
synaptic membrane because manipulations that inter-subsequent LTD. Moreover, the requirement for en-
fere with clathrin-mediated endocytosis block the induc-dogenous CPI-17 in LTD was demonstrated with neu-
tion of cerebellar LTD in culture (Wang and Linden,tralizing antibodies plus gene silencing by siRNA.
2000). Furthermore, application of an exogenous PKCThese interventions had no effect on basal synaptic
activator to produce an LTD-like effect results in inter-strength but blocked LTD induction. Thus, a biochemi-
nalization of AMPA receptors in the dendrites of culturedcal circuit that involves PKC-mediated activation of
Purkinje cells (Matsuda et al., 2000). The processes thatCPI-17 modulates the distinct physiological processes
link PKC activation to AMPA receptor internalization areof vascular contractility and cerebellar LTD.
not completely understood, but phosphorylation of
Ser880 in the carboxy-terminal tail PDZ ligand of the
AMPA receptor subunit GluR2 and the subsequent un-Introduction
binding of GRIP/ABP (Matsuda et al., 1999; Chung et
al., 2000) and recruitment of PICK1 (Chung et al., 2000)Coactivation of climbing fiber and parallel fiber inputs
to this domain appear to be necessary for the expressionto a cerebellar Purkinje cell produces a persistent and
of cerebellar LTD (Xia et al., 2000).
input-specific depression of the parallel fiber-Purkinje
We hypothesize that transient and abrupt phosphory-
cell synapse called cerebellar long-term synaptic de-
lation of a critical substrate such as GluR2 Ser880 by
pression (LTD). This phenomenon has been implicated PKC requires not only PKC activation but also a coordi-
in the engram for several forms of motor learning, includ- nated inhibition of the opposing protein phosphatase.
ing associative eyelid conditioning and adaptation of the Phosphatase inhibition could arise through a signaling
vestibulo-ocular reflex (Bear and Linden, 2000; Hansel et pathway that is separate from and parallel to the kinase.
al., 2001). Since its initial discovery by Ito and coworkers Such a mechanism appears to be operative in the induc-
(1982), the requirements for induction and expression tion of NMDA receptor-dependent hippocampal long-
of cerebellar LTD have been intensively investigated, term potentiation (LTP). In LTP, activation of CaMKII
yet a complete understanding of its biochemical under- is simultaneous with inhibition of the opposing protein
pinnings has remained elusive. Three initial postsynaptic phosphatase 1 (PP1) via a signaling cascade involving
events appear to be required for LTD induction: (1) cAMP, cAMP-dependent protein kinase, and inhibitor-1
mGluR1 activation (Kano and Kato, 1987; Linden et al., (Blitzer et al., 1995, 1998). A similar situation applies to
1991; Shigemoto et al., 1994), (2) Ca2 influx via voltage- vascular smooth muscle, where, in parallel with activa-
gated Ca2 channels (Linden et al., 1991; Konnerth et tion of the Ca/CaM-dependent protein kinase myosin
al., 1992), and (3) AMPA receptor activation (Linden et light chain kinase (MLCK), PKC produces Ca2 sensitiza-
al., 1993; Hemart et al., 1995). These three signals appear tion by inhibition of MMP (a holoenzyme consisting of
to converge upon protein kinase C (PKC), the activation a catalytic subunit of PP1 [PP1C] complexed with regu-
latory subunits) via a PKC-activated myosin/moesin
phosphatase (MMP) inhibitor called CPI-17 (Kitazawa et3 Corrrespondence: dlinden@jhmi.edu
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Figure 1. Postsynaptic Application of Exogenous Phosphatases Blocked LTD Induction
(A) (1) Effects on basal responses in representative single cells. The time axis shows the time after establishing a stable whole-cell recording.
(2) Group data for basal responses. Error bars indicate the SEM in this and all subsequent graphs. n  6 for all groups.
(B) (1) Single cell data. Following acquisition of baseline responses to glutamate, LTD was induced by glutamate/depolarization conjunction
at t  17.5 min as indicated by the horizontal bar. (2) Group data. Representative current traces were acquired at the times indicated on the
graph. Scale bars equal 50 pA, 1 s. n  6 for all groups.
al., 1999). The present study is designed to test the constitutively active, truncated form of human PP5, PP5
(1–486), as well as an inactive point mutant form, PP5general hypothesis that cerebellar LTD induction re-
quires protein phosphatase inhibition, and, more specifi- (H304Q). PP1, PP2A, and PP5 (1–486) all produced small
and insignificant increases in the amplitude of gluta-cally, to evaluate the involvement of a PKC/CPI-17 sig-
naling cascade. mate-evoked currents (109%  7.6%, 112%  7.9%,
and 108%  6.6% of baseline, respectively, measured
at t  50 min post whole-cell, n  6 for all groups). InResults
a second group of Purkinje cells, following 18 min of
baseline recording, LTD was induced by pairing six glu-Whole-cell voltage-clamp recordings were made from
tamate pulses with six, 3 s long depolarizations to 0 mV.Purkinje cells in cultures derived from embryonic mouse
In control Purkinje cells perfused with normal internalcerebellum and maintained in vitro for 7–13 days. Tetro-
saline or inactive PP5 (H304Q), LTD was rapidly induceddotoxin and picrotoxin were added to the external saline
(amplitudes reduced to 60%  8.9% and 58%  8.6%to suppress action potentials and GABAA-mediated
of baseline, respectively, at t  20 min, n  6 for bothsIPSCs, respectively. AMPA receptor-mediated inward
groups) and the effects persisted for the duration of thecurrents were evoked by delivering brief test pulses of
recordings (50%  7.9% and 50%  8.2% of baseline,glutamate through an iontophoretic electrode placed
respectively, t  50 min). However, in cells loaded withclose to a Purkinje cell dendrite. As a first attempt to
active protein phosphatases, while a variable amountassess the role of protein phosphatases in LTD, several
of short-term depression remained, LTD was stronglypurified preparations were added to the patch pipette
suppressed (PP1, 100%  7.4% of baseline; PP2A,while glutamate test pulses were delivered at a fre-
104% 8.2% of baseline; PP5, 85% 8.4% of baselinequency of 0.05 Hz (Figure 1). Purkinje cells have been
at t 50 min, n 6 for all groups). One possible interpre-reported to express protein phosphatases PP1 (Saka-
tation of these data is that the synaptic strength is largelygami et al., 1994; Hashikawa et al., 1995), PP2A (Hashi-
determined by the phosphorylation status of a particularkawa et al., 1995; Strack et al., 1998), PP2B (Kincaid et
substrate (such as synaptic GluR2 Ser880; Chung et al.,al., 1987; Usuda et al., 1996), PP2C (Abe et al., 1992),
2000), which is low in basal conditions (which includeand PP5 (Bahl et al., 2001). The preparations used con-
TTX in the present case). There is little or no synapticsisted of PP1 purified from rabbit skeletal muscle, PP2A
purified from human red blood cells, and a recombinant, potentiation induced by addition of phosphatases, be-
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Figure 2. Phosphatase Inhibitors Produced a Use-Dependent Depression of AMPA Responses that Occluded LTD
(A) (1 and 2) Postsynaptic application of okadaic acid (200 nM, n  6) produced a slowly developing depression of AMPA responses that occluded
subsequent LTD (induced at t  27.5 min) while fostriecin (10 nM, n  7), endothall (200 nM, n  6), and control saline (n  6) did not.
(B) (1 and 2) The slowly developing depression produced by okadaic acid (200 nM; n 6; data copied from [A] for comparison) was accelerated
by doubling the test pulse frequency to 0.1 Hz (n  6) and slowed when test pulses at the normal frequency were paused from 7.5–25 min
(n  7). Inclusion in the patch pipette of the Ca2 chelator BAPTA (20 mM, n  6) or the PKC inhibitor chelerythrine (10 M; n  5) blocked
the use-dependent depression of glutamate responses in the presence of okadaic acid. (3) Representative current traces from the time points
indicated on the graph in (2). Scale bars equal 30 pA, 1 s.
cause kinase activity is low relative to phosphatase ac- and Chen et al., 1994). When applied internally at a
concentration of 200 nM, it produced a slowly develop-tivity during prestimulation and, as a consequence, very
few phosphorylated residues are available as substrates. ing attenuation of the response to glutamate test pulses
(64%  8.4% of baseline, t  27.5 min, n  6) thatHowever, when LTD induction by glutamate/depolariza-
tion pairing occurs, the phosphorylation events that are occluded subsequent induction of LTD (55%  8.1% of
baseline, t  50 min). Fostriecin (10 nM) and endothallnormally produced by a burst of PKC activation are
reduced in number and duration in the presence of exog- (200 nM) are selective inhibitors of PP2A (Li et al., 1993;
Walsh et al., 1997) that produced no significant alterationenous phosphatase.
While the suppression of LTD by exogenous protein in the response to test pulses of glutamate (100% 
5.5% and 100%  5.6% of baseline, t  27.5 min, n phosphatases suggests that this class of enzyme is ca-
pable of modulating LTD induction, it does not directly 7 and n  6, respectively; compare to control internal
saline 102%  5.8% of baseline, n  6). Likewise, LTDaddress the role of endogenous protein phosphatases
in this process. For this purpose, inhibitors of protein induction proceeded normally in the presence of fostrie-
cin or endothall (58%  9.1% of baseline, t  50 min;phosphatases were employed (Figure 2A). We began
with a relatively nonspecific protein phosphatase inhibi- compare to control internal saline, 61%  9.0% and
55%  8.9% of baseline, respectively). To confirm thattor. Okadaic acid inhibits multiple protein phosphatases
including PP1, PP2A, and PP5 (Bialojan and Takai, 1988, these two PP2A inhibitors were active, we performed an
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electrophysiological control experiment: both of these a dramatic attenuation of glutamate-evoked inward cur-
rents (47%  7.0% of baseline, t  27.5 min, n  7),compounds, but not a control solution, produced a
large, time-dependent increase in the open probability which occluded subsequent LTD (53%  9.1% of base-
line, t 50 min; Figure 3B). Similar to the effects of less-of BK channels recorded in whole-cell mode in mouse
cerebellar granule cells (data not shown). This effect is specific PP1 inhibitors, the attenuation of glutamate re-
sponses produced by thiophospho-Thr38 CPI-17 wassimilar to that previously reported in certain nonneuronal
cells by Sansom et al. (1997). Taken together, these use dependent (data not shown). As a negative control,
an inactive point mutant form of CPI-17 (T38A; Eto et al.,results show that reduction of endogenous non-PP2A
phosphatase activity produced a slowly developing at- 2000) was found to be ineffective when it was included in
the patch pipette solution at a concentration of 1 Mtenuation of glutamate responses that occluded LTD.
Why does this attenuation proceed slowly? One possi- (107%  5.3% of baseline, t  27.5 min, n  5).
One possible complication in these experiments isbility is that it is use dependent and requires activation
of glutamate receptors and their sequelae. To test this that the occlusion of LTD by thiophospho-Thr38 CPI-17
might be an artifact of an experimental system usinghypothesis, okadaic acid was applied in the patch pi-
pette and test pulses were delivered at 0.1 Hz, twice exogenous glutamate test pulses that activate a higher
proportion of extrasynaptic receptors than synapticallythe previous frequency (Figure 2B). This resulted in
faster and possibly more complete attenuation of gluta- released glutamate. To address this, experiments were
conducted using evoked monosynaptic EPSCs in gran-mate-evoked currents (48% 7.0% of baseline, t  27.5
min, n 6) and occlusion of LTD. Conversely, when gluta- ule cell-Purkinje cell pairs (Figure 3C). Activation of a
synaptically connected granule cell-Purkinje cell pair atmate pulses were paused from t  7.5 to 25 min, signifi-
cantly less attenuation was observed upon their resump- 0.1 Hz resulted in a mixture of evoked currents and
failures that were averaged (Linden, 1997; Linden andtion (82%  7.2% of baseline, t  27.5 min, n  7).
When either a Ca2 chelator (BAPTA, 20 mM) or a PKC Ahn, 1999; Wang and Linden, 2000). LTD was induced by
applying 60 pulses at 0.5 Hz at the test pulse stimulationinhibitor (chelerythrine, 10M) was applied postsynapti-
cally and test pulses were given at the normal frequency strength to the granule cell, with each pulse paired with
a 100 ms long depolarization of the Purkinje cell to 0 mV.(0.05 Hz), no use-dependent attenuation was observed
(92%  5.6%, and 99%  4.0% of baseline, n  6 and Similar to the results with exogenous glutamate pulses,
thiophospho-Thr38-CPI-17 (1 M) introduced into cellsn  5, respectively, t  27.5 min). This confirms and
extends previous reports in which application of the from the patch pipette produced a dramatic attenuation
of glutamate-evoked inward currents (49%  6.1% ofnonselective phosphatase inhibitors calyculin A or mi-
crocystin-LR (MC-LR) attenuated parallel fiber-Purkinje baseline, t 27.5 min, n  6) that occluded subsequent
LTD (53%  8.7% of baseline, t  40 min). T38A CPI-cell EPSCs in a slice preparation (Ajima and Ito, 1995) or
glutamate responses in a culture preparation (Kasahara 17 (1 uM) had no significant effect on baseline EPSCs
(95%  5.9% of baseline, t  27.5 min, n  6), andand Sugiyama, 1998). One likely explanation for these re-
sults is that increases in the phosphorylation state of a subsequent LTD proceeded normally (61%  8.6% of
baseline, t  40 min). Because of the specificity of CPI-key substrate (such as synaptic GluR2 Ser880), and
hence decreases in the amplitude of glutamate-evoked 17 for MYPT-containing PP1 holoenzymes, these results
suggest that inhibition of MMP forms of PP1 was in-inward currents, are only seen with phosphatase inhibi-
tors when there is concurrent PKC activity driven by volved in the development of LTD. However, the possi-
bility exists that CPI-17 might also bind PP1C com-test pulses.
Cells contain many distinctive forms of PP1 with the plexed with an as-of-yet undiscovered regulatory
subunit unrelated to MYPT.catalytic subunit (PP1C) complexed to dozens of differ-
ent regulatory subunits. The targeting subunit called Further experiments sought to establish whether en-
dogenous CPI-17 was required for LTD. CPI-17 is ex-MYPT1 forms a PP1 holoenzyme we refer to as myosin/
moesin phosphatase (MMP) because MYPT1 binds my- pressed in tonic and phasic smooth muscles at different
levels (Woodsome et al., 2001), but has not been foundosin as well as ezrin/radixin/moesin (ERM proteins; Fu-
kata et al., 1998) and adducin (Kimura et al., 1998), which in other muscles, such as skeletal or cardiac, nor in
various peripheral tissues such as kidney, liver, or inare all substrates dephosphorylated by this holo-
enzyme. PP1 associated with MYPT is specifically inhib- fibroblasts. Immunoblotting and Northern hybridization
showed low levels of CPI-17 in whole-brain extracts thatited by the PKC-activated inhibitor protein called CPI-
17 (Senba et al., 1999; Eto et al., 2000). In rat cerebellar could have been from blood vessels (Eto et al., 1997,
1999). However, we found that CPI-17 is strongly ex-extracts, MYPT1 was detected by immunobloting (Fig-
ure 3A). A constitutively active form of CPI-17, thio- pressed in rat cerebellum (Figure 4A). Furthermore, by
immunohistochemistry with specific antibodies, we dis-phospho-Thr38-CPI-17 (TP-CPI-17), associated with
PP1C complexed with the cerebellar MYPT1. Compared covered that CPI-17 is expressed in several brain re-
gions, including cerebellar Purkinje cells (Figure 4B, seewith MC-LR, a nonselective PP1 inhibitor, the cerebellar
MYPT1 was concentrated in fraction bound to TP-CPI- also Figure 6B). Thus, endogenous CPI-17 may function
as inhibitor of PP1 during cerebellar LTD induction.17. Thus, while CPI-17 inhibits the PP1C monomer, MMP
is selectively associated with phospho-CPI-17, com- The specificity of the anti-CPI-17 antibodies was veri-
fied using biochemical assays with purified MMP (Figurepared with MC-LR, a nonselective PP1 inhibitor. There-
fore, activated CPI-17 provides a useful tool to distin- 5A) as well as immunoblotting (Figures 4A and 5B). Phos-
phatase inhibition by 10 nM phospho-CPI-17 (60%,guish among holoenzymes of the PP1 family as well as
between PP1 and other phosphatases. TP-CPI-17 (1 M) Figure 5A, left) was more potent that with 10 nM of a
related inhibitor protein, phospho-PHI (20%, Figureintroduced into cells from the patch pipette produced
Cerebellar LTD Requires CPI-17 Activation
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Figure 3. CPI-17, an Inhibitor of Myosin/Moesin Phosphatase (MMP) Forms of PP1, Produced a Use-Dependent Depression of AMPA Re-
sponses that Occluded LTD
(A) CPI-17 selectively recognized PP1C complexed with MYPT1 (a MMP holoenzyme) in rat cerebellar extracts. A rat cerebellar extract (Input
Extract) was incubated for 1.5 hr at 4C with ligand beads, unphospho (U)- or thiophospho (TP)-H6S-CPI-17, or the nonselective phosphatase
inhibitor microcystin-LR (MC-LR). After washing, cerebellar proteins bound on ligands were analyzed by immunoblotting using anti-MYPT1
(top) or anti-PP1C (bottom) antibodies. Identical results were obtained in three independent experiments.
(B) (1 and 2) The MMP inhibitor thio-phospho-Thr38-CPI-17 (1 M; n  7), but not the inactive point mutant control protein CPI-17 T38A (1 M;
n  5), produced a depression of glutamate responses that occluded subsequent LTD.
(C) (1 and 2) A mixture of EPSCs and synaptic failures were evoked in granule cell-Purkinje cell pairs. Here, the mean EPSC amplitude (including
failures) is plotted. LTD was induced by applying 60 pulses at 0.5 Hz at the test pulse stimulation strength to the granule cell, with each pulse
paired with a 100 ms long depolarization of the Purkinje neuron to 0 mV (indicated by the horizontal bar). Similar to the result seen with
exogenous glutamate, thio-phospho-Thr38-CPI-17 (n  6) produced an attenuation that occluded subsequent LTD while T38A CPI-17 (n  6)
did not. Current traces are the average of 12 consecutive responses. Scale bars equal 5 ms, 8 pA.
5A, right). Adding the anti-CPI-17 antibodies to the assay patch pipette to introduce them into the cells, no signifi-
cant effect was seen on basal glutamate responsescompletely abolished inhibition by phospho-CPI-17, but
only decreased by about a third the inhibition by phos- (101%  5.8% of baseline, t  15 min, n  7), but
subsequent glutamate/depolarization pairing failed topho-PHI-1. If the antibodies were depleted from the so-
lution by a single step of adsorption against CPI-17, establish LTD (94%  8.6% of baseline, t  50 min; see
Figure 5C). As a negative control, the antibody solutionthen most of the neutralizing activity was removed and
the inhibitory effects of phospho-CPI-17 were evident. was preabsorbed to recombinant CPI-17 protein to de-
plete the specific antibodies. This preabsorbed solutionWhen purified anti-CPI-17 antibodies were added to the
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Figure 4. CPI-17 Immunoreactivity Was
Present in Cerebellar Purkinje Cells
(A) Anti-CPI-17 blot for rat cerebellar CPI-17.
Rabbit ileum, rat cerebellum, and cultured rat
aortic smooth-muscle cells (SMC) were ho-
mogenized with SDS buffer (50 mM Tris-HCl,
1% SDS, 1 mM Na ortho-vanadate, 1 mM
EDTA, 5 mM benzamidine [pH 7.4]). The ho-
mogenate was mixed with 2 SDS sample
buffer and indicated amounts of total proteins
were subjected to immunoblotting. Endoge-
nous CPI-17 was detected using anti-CPI-17
antibody. Number at right indicates molecular
size of standard protein.
(B) Floating section immunohistochemistry
was performed on sagittal slices of cerebellar
vermis from an adult B6C3F1 mouse using a
peroxidase reaction with DAB as a substrate.
Boxes in the top images indicate the regions
shown at higher magnification in the lower
images. GC, granule cell layer; PC, Purkinje
cell layer; ML, molecular layer. Scale bar
equals 80 m.
had no activity, either on glutamate test pulses (103% specifically binds endogenous mRNA and thereby tar-
gets it for an endogenous degradative pathway (see5.2% of baseline, t  15 min, n  6) or subsequent LTD
induction (55%  7.9% of baseline, t  50 min). Similar Hammond et al., 2001, for review). Experiments showed
that CPI-17 siRNA had remarkable efficiency and speci-results were found when this experiment was repeated
using EPSCs evoked in granule cell-Purkinje cell pairs ficity for reducing CPI-17 expression. COS1 cells were
transfected with or without CPI-17 siRNA plus plasmids(Figure 5D).
A second polyclonal antibody was produced and puri- to ectopically express either (1) GFP alone, (2) CFP-
CPI-17, or (3) CFP-PHI-1. Immunoblotting of total cellfied against a synthetic phosphopeptide corresponding
to the Thr38 activation site of CPI-17 (Figure 5B). This proteins with anti-GFP antibodies (which recognize both
CFP and GFP) showed that levels of CFP-CPI-17 wereantibody in the patch pipette produced a similar block-
ade of LTD (101%  8.0% of baseline, t  50 min, n  nearly fully depleted, whereas there was no noticeable
reduction in levels of CFP-PHI-1 fusion protein and little7). Again, as a negative control, the antibody solution
was passed over a phosphopeptide affinity column and change in amount of GFP accumulated in transfected
cells (Figure 6A). Furthermore, when Purkinje cells werethe unbound (depleted) fraction had no effect on either
glutamate test pulses (96%  4.1% of baseline, t  15 treated with particle-mediated transfection using this
specific CPI-17 siRNA, together with a DNA plasmidmin, n  5) or subsequent LTD induction (52%  7.8%
of baseline, t  50 min). Thus, results with two different encoding EGFP as a marker, a strong reduction in CPI-
17 immunoreactivity was seen 24–26 hr later (Figure 6B).purified antibodies indicated that endogenous phos-
pho-Thr38-CPI-17 was required for induction of LTD. Immunohistochemical analysis revealed a 93%  5%
reduction in dendritic and a 85%  7% reduction inThe anti-CPI-17 antibodies are highly specific, but the
family of PKC-activated PP1 inhibitors includes addi- background-corrected total immunoreactivity for CPI-
17 in CPI-17 siRNA-transfected Purkinje cells comparedtional members such as PHI-1 (Eto et al., 1999) and KEPI
(Liu et al., 2002). Thus, we tested for selective gene with those transfected with scrambled CPI-17 siRNA
(n  40 cells/group). These comparisons were per-silencing of CPI-17 by the use of small interfering RNA
(siRNA), a technique in which an introduction of a 21- formed on samples processed together and imaged and
analyzed with identical settings.base segment of complementary double-stranded RNA
Cerebellar LTD Requires CPI-17 Activation
1151
Figure 5. LTD Induction Was Blocked by Postsynaptic Application of Inactivating CPI-17 Antibodies
(A) Specific blockade of CPI-17 inhibitory activity by neutralizing antibody. Inhibition of myosin/moesin phosphatase (MMP) by either phospho-
CPI-17 (left) or by 10 nM phospho-PHI-1 (right) were compared. Samples were assayed in parallel with no addition as a control (C), or added
anti-CPI-17 serum () or anti-CPI-17 serum preadsorbed to remove specific antibodies (P). The anti-CPI-17 antibody fully blocked the inhibition
by CPI-17 but not by the PHI-1. Inhibition of purified pig aorta myosin/moesin phosphatase activity with chicken gizzard phospho-LC20 as
substrate was performed as described previously (Eto et al., 1995). The recombinant inhibitors CPI-17 and PHI-1 were phosphorylated with
purified PKC and added at a concentration of 10 nM, producing 60% and 20% inhibition, respectively. To test antiserum, 1 l was added in
a 20 l reaction prior to assay, and 4 ml of antiserum was preadsorbed against 4 mg of immobilized CPI-17.
(B) Anti-P-CPI-17(Thr38) blot for rat aorta SMC stimulated with phorbol ester. Rat aortic SMC was stimulated for 5 min with indicated
concentration of phorbol-12-myristate-13-acetate (PMA), and then lysed with SDS buffer. Aliquots (20 g of total protein) were subjected to
immunoblotting using anti-P-CPI-17 (Thr38) antibody.
(C) (1 and 2) Postsynaptic application of two different polyclonal antisera, one raised against the entire purified protein (CPI-17 antiserum, 5
g/ml, n  7) and another raised against a synthetic phosphopeptide based on the sequence of the CPI-17 phosphatase interaction domain
(CPI-17 phosphopeptide antiserum, 1g/ml; n 7) had little effect on baseline responses but blocked subsequent LTD induction. Corresponding
controls consisted of CPI-17 antiserum preabsorbed to CPI-17 protein (5 g/ml; n  6) or CPI-17 phosphopeptide antiserum depleted by
affinity purification (5 g/ml; n  5).
(D) (1 and 2) LTD experiments were replicated in granule cell-Purkinje cell pairs with CPI-17 antiserum (5 g/ml, n  6) and preabsorbed CPI-
17 antiserum (5 g/ml, n  5).
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Figure 6. CPI-17 Knockdown Using siRNA
(A) The accumulation of GPF, CFP-CPI-17, and CFP-PHI-1 proteins in transiently transfected COS1 cells was compared with and without
siRNA for CPI-17. Whole-cell lysates were immunoblotted with anti-GFP antibodies that recognize both GFP and CFP to show selective
depletion of the CPI-17 fusion protein without change in the amount of PHI-1 fusion protein.
(B) Particle-mediated transfection of Purkinje cells with CPI-17 siRNA (100 pmol/plate) together with an EGFP expression plasmid produced
a substantial reduction in CPI-17 immunoreactivity when compared with control cells transfected with scrambled CPI-17 siRNA. The EGFP
images were acquired from live cells, and the CPI-17 immunofluorescence was imaged after fixation (which produced tissue shrinkage) and
permeabilization. These are representative neurons from a population of 40/group. At this age (7 days in vitro, necessitated by the transfection
procedure), cultured embryonic Purkinje cells have yet to elaborate tertiary dendrites or spines.
When recordings were made from green fluorescent and induced with synaptic stimulation (100%  3.2%
of baseline at t  7.5 min, compared with 102%  7.3%Purkinje cells 20–54 hr after CPI-17 siRNA transfection,
basal glutamate responses were stable, but LTD was at t  25 min, n  6). Gene silencing was specific for
CPI-17 versus the close relative PHI-1 and reinforcedcompletely suppressed (110%  6.0% of baseline, t 
45 min, n  8; Figure 7A). Purkinje cells transfected the results with purified antibodies, showing that the
activation of CPI-17 and consequent phosphatase inhi-with only an expression vector encoding EGFP or EGFP
together with scrambled CPI-17 siRNA showed normal bition was necessary for induction of LTD.
There is the possibility that the manipulations to sup-LTD (53% 8.5% and 46% 9.0% of baseline, respec-
tively, t  45 min, n  6 for both groups). These experi- press CPI-17 and block LTD induction act through mecha-
nisms other than neutralization or depletion of CPI-17. Toments were then replicated using granule cell-Purkinje
cell pairs to specifically evaluate synaptic glutamate re- address this question, Ca2 imaging was used to measure
two processes that are known to be important for theceptors (Figure 7B). Conjunctive granule cell/depolariza-
tion stimulation to induce LTD produced a significant initial stages of LTD induction, Ca2 influx through volt-
age-gated channels and mGluR1 function (as indexeddecrease in the mean amplitude of evoked EPSCs in
granule cell-Purkinje cell pairs in which the Purkinje cell by quisqualate-evoked Ca2mobilization) in Purkinje cell
dendrites (Table 1). None of the three manipulationswas transfected with scrambled CPI-17 siRNA (97% 
3.1% of baseline at t  7.5 min, prior to pairing, com- used to specifically suppress CPI-17 (two antibodies
and siRNA) produced significant alterations of thesepared with 50%  6.9% at t  25 min, after pairing, n 
6). In contrast, Purkinje cells transfected with CPI-17 measures. Likewise, manipulations that inhibited CPI-
17 produced no alterations in other basal properties ofsiRNA showed a near complete block of LTD monitored
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Figure 7. CPI-17 Knockdown Blocked LTD Induction
(A) (1 and 2) Particle-mediated transfection of CPI-17 siRNA (100 pmol/plate) together with an EGFP expression plasmid produced little effect
on baseline glutamate responses but blocked LTD induction (n  8). Controls consisted of Purkinje cells transfected with the EGFP plasmid
alone (n  6) or together with scrambled CPI-17 siRNA (100 pmol/plate, n  6). Scale bars equal 25 pA, 1 s.
(B) (1 and 2) LTD experiments replicated using granule cell-Purkinje cell pairs. Similar to the result seen with exogenous glutamate, transfection
with CPI-17 siRNA produced a blockade of LTD while scrambled CPI-17 siRNA did not (n  6/group). Traces are the average of 10 consecutive
responses. Scale bars equal 10 pA, 5 ms.
Purkinje cells, including Rinput or the amplitude or kinetics PKC activation in neural tissue results in indirect inhibi-
tion of substrate dephosphorylation via CPI-17 and PP1.of AMPA receptor-mediated mEPSCs.
CPI-17 was originally discovered in arterial smooth
muscle as a MMP inhibitor (Eto et al., 1995). Phosphory-Discussion
lation of Thr38 in CPI-17 produces the active form as a
specific inhibitor of MMP (Senba et al., 1999; Ohki et al.,Endogenous postsynaptic CPI-17 is shown to be re-
quired for cerebellar LTD induction. This implicates a 2001). In arterial smooth muscles, CPI-17 is phosphory-
lated by activated PKC in response to agonist stimuli ofsignaling pathway that coordinates PKC with the oppos-
ing phosphatase, via inhibition by phospho-CPI-17. This G protein-coupled receptors (Kitazawa et al., 2000; Eto
et al., 2001). Depletion of endogenous CPI-17 from smoothis a pathway used in smooth muscle to modulate con-
tractility. Our results show neutralizing endogenous CPI- muscle by membrane permeabilization eliminates PKC-
induced contraction and myosin phosphorylation. Con-17 had specific effects on LTD. First, three independent
manipulations were used to block CPI-17 function (two versely, reconstitution of permeabilized muscles with
recombinant CPI-17 restores the PKC signaling, im-CPI-17 antisera and CPI-17 knockdown by siRNA), and
all attenuated LTD induction (Figures 5 and 7). Second, plying that CPI-17 is necessary for PKC-induced con-
traction of vascular smooth muscle (Kitazawa et al.,for each of these manipulations, the corresponding neg-
ative control (preabsorbed CPI-17 antiserum, depleted 1999). In arterial smooth muscle, agonist stimuli induce
transient elevation of intracellular Ca2 that results inCPI-17 phosphopeptide antiserum, scrambled CPI-17
siRNA) had no effect on LTD induction. Third, these transient activation of Ca2/CaM-dependent myosin
light chain kinase (Figure 8). In addition, the activationmanipulations had no side effects on mGluR1 function or
Ca2 transients produced by depolarization, two signals of PKC induces phosphorylation of CPI-17 and inhibition
of MMP that maintain phosphorylation of myosin afterthat are critical early steps for LTD induction (Table 1).
Finally, these manipulations had no general effects on attenuation of intracellular Ca2 (called Ca2 sensitiza-
tion). Similarly CPI-17 mediates PKC signaling in Pur-cell health or the function of synaptic AMPA receptors
as indicated by measures of Rinput or the amplitude or kinje cells. The cells where CPI-17 is neutralized with
specific antibodies or siRNA showed small depressionskinetics of AMPA-mEPSCs. This constitutes the first evi-
dence implicating phosphatase inhibition in LTD at any of glutamate responses that rapidly returned to basal
levels. The results suggest that phosphorylation of CPI-brain location. Furthermore, it is the first evidence that
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many different regulatory/targeting subunits to consti-
tute holoenzymes with varying properties, and these
holoenzymes cannot be further differentiated by drugs
such as okadaic acid or related compounds. In contrast,
CPI-17 selectively associates with MMP, consisting of
PP1C and the myosin targeting subunit (Senba et al.,
1999), and ectopic expression of CPI-17 induces inhibi-
tion of MMP in living cells (Eto et al., 2000), suggesting
selective recognition against MMP. Indeed CPI-17 se-
lectively associated with MMP in a rat cerebellar extract
(Figure 3A). When a constitutively active form of CPI-17
(thio-phospho-CPI-17, 1 M) was added to the internal
saline, a dramatic attenuation of glutamate-evoked in-
ward currents was produced and this occluded subse-Figure 8. A Schematic Diagram Illustrating Some of the Signaling
quent LTD (Figures 3B and 3C). Thus, endogenous, post-Steps We Believe to be Involved in the Induction of LTD in Cerebellar
synaptic CPI-17 appears to be involved in cerebellarPurkinje Cells and the Development of Ca2 Sensitization in Vascular
Smooth Muscle LTD. When taken together with the experiments that
VSCC, voltage-sensitive Ca2 channels; MLCK, myosin light chain have used inactivating antisera and siRNA approaches
kinase; MLC20, myosin light chain 20; GPCR, G protein coupled to interfere with endogenous postsynaptic CPI-17 (Fig-
receptor. Arrowheads indicate activation while flat bars represent ures 5 and 7), a signaling cascade involving PKC, activa-
inhibition.
tion of CPI-17 appears to be required for cerebellar LTD
induction. A hypothesis of the molecular mechanism for
cerebellar LTD is that the phosphorylation at Ser880 of17 is required for maintenance of LTD. In cerebellar LTD
GluR2 (Matsuda et al., 1999, 2000; Chung et al., 2000)it seems that a single kinase, PKC, produces a bifurcated
results in internalization of AMPA receptors (Wang andsignal converging on substrate, compared to smooth-
Linden, 2000; Xia et al., 2000). Inhibition of MMP bymuscle Ca2 sensitization (or hippocampal LTP) where
phospho-CPI-17, together with coincident PKC activa-two different kinases act in parallel, one to phosphory-
tion, might increase phosphorylation of Ser880 andlate substrate and the other to inhibit PP1 via an inhibitor
thereby promote the internalization of GluR2-containingprotein (Figure 8).
AMPA receptors or block their reinsertion in the synapticInterestingly, in both the present experiments and pre-
plasma membrane.vious reports (Ajima and Ito, 1995; Kasahara and Sugiya-
There are a number of questions that are raised by thema, 1998), compounds that inhibited PP1 produced a
present findings. One is the developmental regulationslowly developing attenuation of glutamate responses.
of this phosphatase cascade. The present experimentsOne possibility is that this time course reflects slow
were performed in embryonic tissue culture and it willaccess of the drugs to their targets. However, this seems
be instructive to determine if this mechanism persistsunlikely as similar time courses were seen with applica-
in mature Purkinje cells. Another is the exact moleculartion in the patch pipette (the present experiments) and
identity of Purkinje cell MMP and the characterizationthe bath (Kasahara and Sugiyama, 1998). Experiments
of its binding partners and subcellular localization. Inin which test pulses were paused during okadaic acid
addition to MYPT1 and MYPT2 isoforms, PP1C associ-application or doubled in frequency produced corre-
ated with related structures such as MYPT3 (Skinnersponding decreases and increases in the rate of gluta-
and Saltiel, 2001) and p85 (Tan et al., 2001) might be amate response attenuation, suggesting that this phe-
target of CPI-17. Although MMP is a strong candidatenomenon is use dependent (Figure 2B). The attenuation
of a target PP1 for CPI-17, our results cannot excludeof glutamate responses was also completely blocked in
possible involvement of another PP1 complex in cere-Purkinje cells in which the Ca2 chelator BAPTA (20 mM)
bellar LTD. A third question is the identity of those phos-or the PKC inhibitor chelerythrine (10 M) was added
phatase substrates important for cerebellar LTD induc-to the patch pipette. Thus, rate of attenuation seems to
tion. It is likely that at least one of these will be Ser880depend on PKC activity in the cells. Therefore, inhibition
of the AMPA receptor GluR2. Phosphorylation of thisof phosphatases by inhibitor compounds is not suffi-
residue by PKC results in internalization of AMPA recep-cient to induce a rapid attenuation under basal condi-
tors (Matsuda et al., 1999; Chung et al., 2000) and thetions. We hypothesize that the phosphorylation state of
consequent unbinding of GRIP and recruitment of PICK1a key substrate (such as synaptic GluR2 Ser880) deter-
that is required for LTD induction (Xia et al., 2000). How-mines the amplitude of glutamate-evoked inward cur-
ever, it is quite possible that GluR2 Ser880 is not therents and changes are only produced by PP1 inhibitors
only relevant phosphatase substrate, particularly for thewhen there is conjoint test pulse-driven PKC activity. It
protein synthesis-dependent late phase that beginsis worthwhile to note that this model may not hold at
45–60 min after LTD induction (Linden, 1996; Ahn etall other CNS synapses. For example, in hippocampal
al., 1999). It will be particularly interesting to determineSchaffer collateral-CA1 synapses, loading cells with PP1
whether inhibition of MMP affects actomyosin contrac-inhibitors blocked synaptically evoked LTD. PP1 simi-
tility or the function of other myosin isoforms (e.g., re-larly failed to alter basal synaptic strength, but enhanced
ceptor internalization?) within dendritic spine heads andrather than blocked subsequent induction of LTD (Mori-
whether this is involved in long- or short-term modula-shita et al., 2001).
The catalytic subunit of PP1 (PP1C) can complex with tion of synaptic function.
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Experimental Procedures Ca2 Imaging
Bis-fura-2 ratio imaging of intracellular free Ca2 was accomplished
by measuring the background corrected fluorescence ratio at 340Cell Cultures and Patch Clamp Recording
Mouse embryonic cerebellar cultures were prepared as previously and 380 nm excitation using a cooled CCD camera system as pre-
viously described (Narasimhan and Linden, 1996). In these experi-described (Linden, 2001). Cultures were maintained for 9–16 days in
vitro prior to their use in patch-clamp experiments. For conventional ments, EGTA was removed from the internal saline and replaced
with 100 M bis-fura-2. In a subset of experiments examining quis-whole-cell recording, patch electrodes attached to Purkinje neuron
somata were filled with a solution containing CsCl (135 mM), HEPES qualate-evoked Ca2 mobilization, Ca2 was removed from the ex-
ternal saline and was replaced with 0.2 mM EGTA.(10 mM), EGTA (0.5 mM), Na2-ATP (4 mM), and Na-GTP (0.4 mM),
adjusted to pH 7.35 with CsOH. Cells were bathed in NaCl (140 mM),
KCl (5 mM), CaCl2 (2 mM), MgCl2 (0.8 mM), HEPES (10 mM), glucose
Preparation of CPI-17 Antibodies and Proteins(10 mM), D-AP5 (0.1 mM), TTX (0.0005 mM), and picrotoxin (0.3 mM),
Rabbit anti-CPI-17 serum was prepared using recombinant pig CPI-adjusted to pH 7.35 with NaOH, which flowed at a rate of 0.5 ml/
17 as an antigen (Eto et al., 2000). The anti-CPI-17 recognized onlymin. Patch electrodes were pulled from N51A glass and polished
endogenous CPI-17 in tissue extracts (Figure 4A). The control serumto yield a resistance of 2–4 M	. Iontophoresis electrodes (1 m tip
was prepared using CPI-17-conjugated Affigel 10 beads. The spe-diameter) were filled with 10 mM glutamate or kainate (all in 10 mM
cific antiserum (4 ml) was mixed with Affigel 10 beads (4 ml) conju-HEPES [pH 7.1]) and were positioned 20 m away from large-
gated with H6S-CPI-17 (4 mg) overnight at 4C. The unbound serumcaliber dendrites. Test pulses were delivered using negative current
was used as the control absorbed serum. Anti-phospho-CPI-pulses (600–900 nA, 30–110 ms duration). Some experiments utilized
17(Thr38) was prepared and purified using phospho-H6S-CPI-17 assynaptic activation of granule cell-Purkinje cell pairs, as has been
described previously (Kitazawa et al., 2000). The anti-P-CPI-17previously described (Linden, 2001). For these experiments, TTX
(Thr38) recognized only P-CPI-17 induced by PKC activation (Figurewas omitted from the external saline, and granule cells were acti-
5B). Immunohistochemistry was performed according to the methodvated using 0.5 ms long constant-voltage pulses through a loose-
of Xia et al. (2000).patch electrode (5–6 M	) filled with external saline. Membrane cur-
Recombinant CPI-17 tagged with a 44-residue N-terminal His6-rents were recorded with an Axopatch 200A amplifier and digitized
plus S-TagTM (H6S-) was prepared as described previously (Eto etat 10–20 kHz. Signals were lowpass filtered using an 8-pole Bessell
al., 1997). Briefly, pig cDNA encoding the full-length CPI-17 wasfilter at 5 kHz. Analysis was performed using Axograph 4.5 software.
subcloned into pET30 vector (Novagen). The H6S-tag of the recombi-Recordings in which Rinput or Rseries varied by more than 9% were
nant protein enabled the use of Ni-NTATM (Qiagen) and S-proteinTMexcluded from the analysis. Tetrodotoxin was from Alexis Biochemi-
(Novagen) agaroses for affinity resin. The H6S-tagged CPI-17 wascals. Purified PP1 and PP2A were from Upstate Biotechnology, trun-
expressed in E. coli (BL21(DE3)) and purified by Ni-NTA agarosecated constitutively active (1–486) and mutant inactive (H304Q) PP5
column chromatography. Phosphorylation and thiophosphorylation ofwere kindly provided by Sandra Rossie (Purdue University). All other
H6S-CPI-17 was performed using the pig aorta PKC active fragmentreagents were from Sigma. Immunohistochemistry was performed
(Eto et al., 2001), and ATP or ATPS as-phosphate or-thiophosphateaccording to the methods of Xia et al. (2000). Analysis of immunohis-
donors (Hayashi et al., 2001). Thiophospho (TP)-H6S-CPI-17 wastochemical images was performed using IPLab software.
identical to the phospho-form in the inhibitory activity for myosin
phosphatase and more stable compared with the phospho-form
(Hayashi et al., 2001). Recombinant proteins and antisera for patchsiRNA
siRNA was diluted in RNase-free ddH2O to yield a concentration of clamp recording were dialyzed overnight against 25 mM HEPES-
KOH (pH 7.2).20 M. Thirty microliters of this solution was mixed with 2 mg of
0.6 m gold microcarriers (Bio-Rad) in a 50% glycerol solution and
6.5 g of a DNA plasmid encoding EGFP. Following vortexing and
Pull-Down Assayan ethanol wash, microcarrier-containing solution was evaporated
Rat cerebella (0.4 g) were minced and homogenized with 4 ml ofon the surface of six macrocarrier discs and delivered to the cerebel-
lysis buffer (50 mM 3-morpholinopropanesulfonic acid-NaOH [pHlar cultures using the Helios Gene Gun System (Bio-Rad) operating
7.0], with 100 mM NaCl, 1 mM EGTA, 5% glycerol, 0.1% Triton X-100,at a pressure of 450 psi and a vacuum of 20 in-Hg. Conditioned
0.2% 2-mercaptethanol, 5 g/ml leupeptin, 0.4 mM PefablocTM, andmedium was aspirated from the surface of the cell culture immedi-
10 g/ml lima bean trypsin inhibitor). Following incubation for 15ately before transfection and was returned immediately thereafter.
min on ice, the extract was clarified by centrifugation for 10 min atThe alignment of CPI-17 siRNA sequence is as follows: CPI-17,
20,000  g. Aliquots of the extract were snap-frozen with liquid N2AAGTGGATCGACGGATGCTTG; PHI-1, G--------TTTA-A-CAGC-C.
and stored at 
80C until use. The extract (0.6 ml) was preclearedOnly 11 out of 21 nucleotides in siRNA for mouse CPI-17 is matched
with unphospho (U)-H6S-CPI-17 (10 g) on S-protein-agarose beadswith corresponding sequence of mouse PHI-1. There is no sequence
(10 l; Novagen). The precleared extract (0.15 ml, each) was mixedinformation of KEPI in database. The sequence of human KEPI at
for 1.5 hr at 4C with 20 l of S-protein agarose or 30 l of Affigelthis region is highly conserved with that of PHI-1 but not CPI-17.
10TM conjugated with (1) U-H6S-CPI-17 (10 g), (2) thiophospho (TP)-Only CPI-17 sequence was hit by BLAST search against sequence
H6S-CPI-17 (10g), and (3) microcystin-LR (MC-LR). Following threeof siRNA. CPI-17 siRNA was ordered from Dharmacon Research
times washing with 0.15 ml of lysis buffer, 20 l of 2 Laemmli SDS-(Lafayette, CO) in purified, desalted, 2-deprotected duplex form.
buffer was added. The SDS samples were subjected to immunoblot-The sequence, which begins about 150 bases downstream from
ting using anti-pan-PP1C (1:1000, Transduction Laboratories) orAUG, was selected based on the criteria of Elbashir et al. (2001).
anti-MYPT1 (1:1000, Upstate Biotechnology). Immunoblotting wasThe sequence of the sense strand was 5-AAGUGGAUCGACG
performed as described previously (Eto et al., 2000).GAUGCUUG-3 with dTdT overhangs. This sequence has relatively
low similarity to CPI-17 orthologs (such as PHI-1 and KEPI) and
yields no additional significant hits in a BLAST search of a mouse Acknowledgments
EST database. A control scrambled siRNA had the sequence 5-
AAAGCUAGGUGGUUCGUAGGC-3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